Detail
| LncRNA Name | CFLAR-AS1 |
| Synonyms | CFLAR-AS1, ALS2CR10 |
| Region | GRCh38_2:201140278-201157823 Sequence |
| Ensembl | ENSG00000226312 |
| RefSeq | NR_040030 |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | esophageal squamous cell cancer |
| ICD-0-3 | |
| Methods | microarray, qPCR etc. |
| Sample | ESCC tissues |
| Expression Pattern | up-regulated |
| Function Description | Further validation in a larger cohort including 205 ESCC patients, 82 patients suffering from esophagus dysplasia and 210 healthy controls confirmed that increased Linc00152, CFLAR-AS1 and POU3F3 might be potential biomarkers for predicting the early progress. We also revealed that circulating levels of three lncRNAs were associated with poor post-surgery prognosis of ESCC patients. |
| Pubmed ID | 27855375 |
| Year | 2016 |
| Title | Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma. |
| External Links |
| Links for CFLAR-AS1 | GenBank HGNC lncrnadb Noncode |
| Links for esophageal squamous cell cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.